Related Experiment Video
Updated: Apr 27, 2026
04:25
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
10.0K
Maxillary osteosarcoma: two case reports and literature review.
Abdulmalak Al-Yahya1, Abdulaziz BinAhmed, Talal Alshammari
1Department of Oral and Maxillofacial Surgery, King Abdulaziz Medical City, Riyadh, Saudi Arabia; Tel: +966 50 416 9769;
Oral Health and Dental Management
|July 3, 2014
Summary
Neoadjuvant chemotherapy offers a viable treatment option for rare maxillary osteosarcoma, demonstrating effectiveness in reducing tumor size and inducing necrosis. This approach, alongside surgical resection, is crucial for improving patient prognosis in this challenging cancer.
Area of Science:
- Oncology
- Surgical Oncology
- Chemotherapy
Background:
- Osteosarcoma is a rare but aggressive malignant bone tumor.
- Maxillary osteosarcoma presents unique challenges due to its location.
- Surgical resection with clear margins is the primary prognostic factor.
Purpose of the Study:
- To evaluate the efficacy of neoadjuvant chemotherapy in maxillary osteosarcoma.
- To present two case studies of maxillary osteosarcoma treated with neoadjuvant chemotherapy.
- To review existing literature on neoadjuvant chemotherapy for this condition.
Main Methods:
- Case report of two patients with maxillary osteosarcoma.
- Administration of neoadjuvant chemotherapy prior to surgical intervention.
- Histopathological assessment of tumor necrosis post-chemotherapy.
- Literature review of similar cases and treatment outcomes.
Main Results:
- Neoadjuvant chemotherapy demonstrated a positive effect on tumor management.
- Variable degrees of tumor necrosis were observed following chemotherapy.
- Surgical outcomes were analyzed in conjunction with chemotherapy response.
- Literature supports chemotherapy as an adjunct to surgery.
Conclusions:
- Neoadjuvant chemotherapy is a potentially effective treatment modality for maxillary osteosarcoma.
- Chemotherapy can induce tumor necrosis, potentially improving surgical outcomes.
- Further research and case studies are warranted to optimize treatment protocols.
